Ampio Pharmaceuticals, Inc.
(NYSE Amex Equities : AMPE)

( )
AMPE After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
2.06%21.3314.1%$125.51m
MDCOMedicines Company
1.72%53.0920.3%$104.73m
GWPHGW Pharmaceuticals PLC Sponsored ADR
3.55%120.336.2%$95.99m
AMRNAmarin Corporation Plc Sponsored ADR
2.65%15.861.8%$84.76m
JAZZJazz Pharmaceuticals Plc
0.34%118.052.3%$59.26m
SAGESAGE Therapeutics, Inc.
3.54%144.268.6%$55.96m
PRGOPerrigo Co. Plc
1.45%53.826.8%$52.09m
PCRXPacira Pharmaceuticals, Inc.
4.07%38.1010.5%$45.60m
UTHRUnited Therapeutics Corporation
0.89%81.9714.3%$39.43m
CTLTCatalent Inc
1.84%49.232.4%$35.25m
HZNPHorizon Pharma plc
3.35%28.206.6%$35.07m
ICLRICON Plc
0.27%141.024.1%$32.80m
ICPTIntercept Pharmaceuticals, Inc.
5.62%64.2516.9%$32.03m
AERIAerie Pharmaceuticals, Inc.
2.92%20.286.8%$28.14m
AXSMAxsome Therapeutics, Inc.
13.10%20.632.0%$25.52m

Company Profile

Ampio Pharmaceuticals, Inc. is a biopharmaceutical company, that engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation, sexual dysfunction and CNS disease. The company was founded by David Bar-Or in April 2010 and is headquartered in Englewood, CO.